Category: Advances in Hepatology
               Diagnosis and Management of Portal Vein Thrombosis in Patients With Cirrhosis
               
               
G&H Is there any need for portal vein thrombosis screening in patients with compensated cirrhosis who do not have any symptoms? JL This is a very […]
               Examining the Recent AASLD/IDSA Guidance Test-and-Treat Algorithm Using Point-of-Care HCV RNA Testing
               
               
G&H What are the main challenges of current hepatitis C virus treatment? AA The biggest challenge of hepatitis C virus (HCV) treatment is not the treatment […]
               Insights Into Liver Transplant Disparities
               
               
G&H What liver transplant disparities have been seen in terms of sex? VL When thinking about disparities in liver transplant, it is important to consider disease […]
               Management of Patients With Refractory Ascites
               
               
G&H What are the typical first steps of management for ascites? SA Ascites, or the buildup of fluid in the abdominal cavity, is related to liver […]
               Prophylaxis for Spontaneous Bacterial Peritonitis
               
               
G&H What is spontaneous bacterial peritonitis, and what are its potential consequences? RS Spontaneous bacterial peritonitis (SBP) is defined as an infection of ascitic fluid without […]
               Update on the Management of Cholestatic Pruritus
               
               
G&H Why is cholestatic pruritus important, and how can it affect patients? KB Cholestatic pruritus, or itch, is important because it affects the majority of patients […]
               Azathioprine or Mycophenolate Mofetil: Which Should Be Used in Patients With Autoimmune Hepatitis?
               
               
G&H How effective and safe is the use of azathioprine in patients with autoimmune hepatitis? AB Autoimmune hepatitis is a chronic inflammatory liver disorder characterized by […]
               Can One Plant-Based Meal a Day Help Patients With Hepatic Encephalopathy?
               
               
G&H What are the nutritional needs of patients with hepatic encephalopathy? JB The nutritional needs of patients with hepatic encephalopathy (HE) are very complicated because these […]
               Highlights From the Recent World Health Organization Guidelines for Hepatitis B Virus Infection
               
               
G&H How much progress has been made, particularly in the United States, toward achieving the World Health Organization goal of global hepatitis B elimination by 2030? […]
               Management of Suboptimal Response in Primary Biliary Cholangitis Treatment
               
               
G&H Currently, what are the main treatment goals for primary biliary cholangitis? GH The goals of primary biliary cholangitis (PBC) treatment are evolving and becoming more […]
               Management of Gastric Varices Using Retrograde Transvenous Obliteration Procedures
               
               
G&H When should retrograde transvenous obliteration be considered in the management of gastric varices? EL Gastric varices are the second most common type of varices in […]
               Highlights From the Recent AASLD Practice Guidelines on Noninvasive Assessment of Hepatic Fibrosis and Steatosis
               
               
G&H Why were guidelines recently released on noninvasive assessment of hepatic fibrosis and steatosis, and how were they developed? RS Understanding the fibrosis stage is paramount […]
               Overview of Pruritus Management in Patients With Chronic Liver Disease
               
               
G&H How common is pruritus in patients with chronic liver disease? AB Overall, the incidence of pruritus or itching in patients with chronic liver disease has […]
               Current Management of Patients With Alcohol-Associated Hepatitis
               
               
G&H How has alcohol use changed since the COVID-19 pandemic? BL Heavy alcohol use had been declining before the COVID-19 pandemic. The pandemic saw a significant […]
               Update on Transjugular Intrahepatic Portosystemic Shunt Use in Liver Disease
               
               
G&H Which patients should be considered for early use of a transjugular intrahepatic portosystemic shunt? JB There has been some movement away from previous practice approximately […]
               Perioperative Risk in Patients With Cirrhosis
               
               
G&H Why do patients with cirrhosis have an increased risk of perioperative morbidity and mortality? KJ Patients with cirrhosis typically have hepatocellular dysfunction and portal hypertension, […]
               Frailty, Sarcopenia, and Nutrition in Patients With Cirrhosis
               
               
G&H Why is it important to identify frailty and sarcopenia in patients with cirrhosis? JL Frailty and sarcopenia are unfortunately prevalent in patients with cirrhosis. Up […]
               Current and Emerging Treatments for Autoimmune Hepatitis
               
               
G&H What is the current understanding of autoimmune hepatitis and its pathogenesis? EW Autoimmune hepatitis (AIH) is a composite of diseases marked by immune dysregulation targeting […]
               Reflecting on a Decade of Sofosbuvir Use for Hepatitis C Virus Treatment
               
               
G&H Sofosbuvir was approved with ribavirin or pegylated interferon plus ribavirin just over 10 years ago for the treatment of hepatitis C virus infection. Thinking back […]
               Highlights From the ACG Guidelines for Acute Liver Failure
               
               
G&H Why were guidelines recently released for acute liver failure? AS The previous North American guidelines on acute liver failure had been released over a decade […]
